The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $55.80

Today's change-0.70 -1.24%
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $55.80

Today's change-0.70 -1.24%
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.

ResMed Inc crosses below 200-day moving average

ResMed Inc closed lower Friday, dropping (U.S.)$0.70 or 1.24% to (U.S.)$55.80 and crossing below its 200-day moving average. Shares have lost 8.10% over the last five days, but have gained 3.93% over the last year to date. This security has underperformed the S&P 500 by 10.96% during the last year.

Key company metrics

  • Open(U.S.) $56.43
  • Previous close(U.S.) $56.50
  • High(U.S.) $56.65
  • Low(U.S.) $55.43
  • Bid / Ask-- / --
  • YTD % change+3.93%
  • Volume1,188,087
  • Average volume (10-day)1,274,211
  • Average volume (1-month)1,109,382
  • Average volume (3-month)1,177,758
  • 52-week range(U.S.) $48.99 to (U.S.) $66.62
  • Beta0.65
  • Trailing P/E22.80×
  • P/E 1 year forward21.06×
  • Forward PEG2.01×
  • Indicated annual dividend(U.S.) $1.20
  • Dividend yield2.15%
  • Trailing EPS(U.S.) $2.45
Updated April 29 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.47%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue454455412453
Total other revenue--------
Total revenue454455412453
Gross profit260267239259
Total cost of revenue194188173194
Total operating expense350347314354
Selling / general / administrative119118111129
Research & development28292729
Depreciation / amortization5422
Interest expense (income), net operating--------
Unusual expense (income)47--0
Other operating expenses, total--------
Operating income10410898100
Interest income (expense), net non-operating-------6
Gain (loss) on sale of assets--------
Other--------
Income before tax10911499104
Income after tax88918087
Income tax, total21231917
Net income88918087
Total adjustments to net income--------
Net income before extra. items88918087
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items88918087
Inc. avail. to common incl. extra. items88918087
Diluted net income88918087
Dilution adjustment--------
Diluted weighted average shares141141142143
Diluted EPS excluding extraordinary itemsvalue per share0.630.640.570.61
Dividends per sharevalue per share--0.300.300.28
Diluted normalized EPSvalue per share0.650.680.570.61